FDA Inspection
Jonathan K. Wise, M.D.Jonathan K. Wise, M.D. – FDA Inspection, Mar 14, 2012
Record Details
This FDA Inspection record concerns Jonathan K. Wise, M.D., with an inspection on March 14, 2012, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Jonathan K. Wise, M.D.
- Inspection Date
- March 14, 2012
- Product Type
- Drugs
View Company Profile
ID · c063c3cd-c2e7-4643-be0d-573192ffe8c3
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 774302
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 312.62(b)Case history records- inadequate or inadequate
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Jonathan K. Wise, M.D.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| December 13, 2017 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| February 5, 2014 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| March 14, 2012 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Jonathan K. Wise, M.D.
- FDA Inspection 1036284 - 2017-12-13
- FDA Inspection 865143 - 2014-02-05
- FDA Inspection 774243 - 2012-03-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.